VIR Vir Biotechnology, Inc.
Nasdaq · SEC CIK 1706431 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $21.00M 38 sales by 10 insiders
- Filings on record
- 298 since 2021-07-06, latest 2026-08-12 14:30
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| SVF Endurance (Cayman) Ltd | 10% | — | $9.38M |
| SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $5.72M |
| SOFTBANK VISION FUND (AIV M1) L.P. | 10% | — | $2.76M |
| SATO VICKI L | Dir | — | $1.73M |
| De Backer Marianne | Pres, CEO, Dir | — | $946.9K |
| de Verneuil Vanina | EVP, GC, Corp Sec | — | $217.7K |
| Sabatini Brent | SVP, CAO | — | $113.1K |
| O'Byrne Jason | EVP, CFO | — | $68.9K |
| Eisner Mark | EVP, Chief Medical Off | — | $49.5K |
| Napolitano Janet | Dir | — | $30.2K |
Transactions 390
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-03 | 2024-05-30 | VIR | MORE ROBERT J | Dir | A - Grant | $0.00 | +8,000 | 46.7K | +21% | $0 |
| D | 2024-06-03 | 2024-05-30 | VIR | NELSEN ROBERT | Dir | A - Grant | $0.00 | +8,000 | 584.1K | +1% | $0 |
| D | 2024-06-03 | 2024-05-30 | VIR | Ramasastry Saira | Dir | A - Grant | $0.00 | +8,000 | 18.6K | +75% | $0 |
| D | 2024-06-03 | 2024-05-30 | VIR | SATO VICKI L | Dir | A - Grant | $0.00 | +8,000 | 1.32M | +0.6% | $0 |
| D | 2024-06-03 | 2024-05-30 | VIR | Sigal Charles Elliott | Dir | A - Grant | $0.00 | +8,000 | 23.8K | +51% | $0 |
| D | 2024-06-03 | 2024-05-30 | VIR | Napolitano Janet | Dir | A - Grant | $0.00 | +8,000 | 23.8K | +51% | $0 |
| D | 2024-06-03 | 2024-05-30 | VIR | Hatfield Jeffrey S. | Dir | A - Grant | $0.00 | +8,000 | 23.8K | +51% | $0 |
| D | 2024-06-03 | 2024-05-30 | VIR | SCANGOS GEORGE A | Dir | A - Grant | $0.00 | +8,000 | 121.0K | +7% | $0 |
| D | 2024-05-31 | 2024-05-29 | VIR | BISCHOFBERGER NORBERT W | Dir | A - Grant | $0.00 | +16.0K | 16.0K | New | $0 |
| D | 2024-05-31 | 2024-05-29 | VIR | Farid Ramy | Dir | A - Grant | $0.00 | +16.0K | 16.0K | New | $0 |
| 2024-04-04 | 2024-04-03 | VIR | De Backer Marianne | CEO, Dir | S - Sale | $9.46 | -73.0K | 678.5K | -10% | -$690.5K | |
| 2024-04-02 | 2024-04-01 | VIR | HANLY ANN M. | EVP, CTO | S - Sale | $10.05 | -2,711 | 132.1K | -2% | -$27.2K | |
| 2024-03-28 | 2024-03-27 | VIR | Lee Sung | EVP, CFO | S - Sale | $9.89 | -6,008 | 100.5K | -6% | -$59.4K | |
| D | 2024-02-26 | 2024-02-22 | VIR | Lee Sung | EVP, CFO | A - Grant | $0.00 | +40.0K | 106.5K | +60% | $0 |
| M | 2024-02-26 | 2024-02-22+ | VIR | SCANGOS GEORGE A | Dir | S - Sale | $11.07 | -27.8K | 130.7K | -18% | -$307.2K |
| D | 2024-02-26 | 2024-02-22 | VIR | De Backer Marianne | CEO, Dir | A - Grant | $0.00 | +175.0K | 751.5K | +30% | $0 |
| D | 2024-02-26 | 2024-02-22 | VIR | HANLY ANN M. | EVP, CTO | S - Sale | $10.05 | -12.3K | 134.8K | -8% | -$123.6K |
| D | 2024-02-26 | 2024-02-22 | VIR | HANLY ANN M. | EVP, CTO | A - Grant | $0.00 | +32.5K | 147.1K | +28% | $0 |
| 2024-02-26 | 2024-02-22 | VIR | Pang Phillip | EVP, Chief Medical Off | S - Sale | $10.05 | -14.6K | 250.1K | -6% | -$146.4K | |
| M | 2024-02-20 | 2024-02-16+ | VIR | SCANGOS GEORGE A | Dir | S - Sale | $10.23 | -27.8K | 157.6K | -15% | -$283.8K |
| 2024-02-16 | 2024-02-16 | VIR | Pang Phillip | EVP, Chief Medical Off | S - Sale | $10.24 | -3,321 | 264.7K | -1% | -$34.0K | |
| DM | 2024-01-03 | 2024-01-02 | VIR | Pang Phillip | EVP, Chief Medical Off | M - OptEx | $1.38 | +80.0K | 268.0K | +43% | +$110.5K |
| 2023-10-20 | 2023-10-19 | VIR | MORE ROBERT J | Dir | J - Other | $0.00 | -6,405 | 38.7K | -14% | $0 | |
| I | 2023-10-20 | 2023-10-19 | VIR | MORE ROBERT J | Dir | J - Other | $0.00 | +6,405 | 495.9K | +1% | $0 |
| 2023-10-18 | 2023-10-17 | VIR | SCANGOS GEORGE A | Dir | J - Other | $0.00 | -1.75M | 168.5K | -91% | $0 | |
| MI | 2023-10-18 | 2023-10-17 | VIR | SCANGOS GEORGE A | Dir | J - Other | $0.00 | +1.75M | 0 | New | $0 |
| MI | 2023-09-18 | 2023-09-15 | VIR | SCANGOS GEORGE A | Dir | J - Other | $0.00 | -3.63M | 0 | -100% | $0 |
| 2023-09-18 | 2023-09-15 | VIR | SCANGOS GEORGE A | Dir | J - Other | $0.00 | +1.75M | 1.92M | +1,039% | $0 | |
| I | 2023-07-05 | 2023-06-30 | VIR | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | S - Sale | $25.11 | -700 | 16.68M | -0.0% | -$17.6K |
| 2023-07-03 | 2023-06-30 | VIR | SATO VICKI L | Dir | S - Sale | $24.66 | -18.0K | 1.32M | -1% | -$443.9K | |
| MI | 2023-06-30 | 2023-06-28+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $25.17 | -97.0K | 16.77M | -0.6% | -$2.44M |
| I | 2023-06-22 | 2023-06-20 | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $25.18 | -9,902 | 16.78M | -0.1% | -$249.3K |
| MI | 2023-06-20 | 2023-06-15+ | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $25.56 | -183.3K | 16.79M | -1% | -$4.69M |
| MI | 2023-06-15 | 2023-06-13+ | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $26.75 | -164.1K | 17.01M | -1.0% | -$4.39M |
| D | 2023-06-08 | 2023-06-07 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $1.53 | +5,000 | 193.0K | +3% | +$7,650 |
| D | 2023-06-08 | 2023-06-07 | VIR | Pang Phillip | Chief Medical Off | S - Sale+OE | $25.95 | -5,000 | 188.0K | -3% | -$129.8K |
| MI | 2023-06-06 | 2023-06-02+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $27.32 | -39.6K | 17.14M | -0.2% | -$1.08M |
| 2023-06-02 | 2023-06-01 | VIR | Rice Steven J. | Chief Administrative Off | S - Sale | $25.67 | -2,500 | 106.8K | -2% | -$64.2K | |
| 2023-06-02 | 2023-06-01 | VIR | Ramasastry Saira | Dir | S - Sale | $25.67 | -3,500 | 10.6K | -25% | -$89.8K | |
| MI | 2023-05-25 | 2023-05-23+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $26.46 | -274.5K | 17.28M | -2% | -$7.26M |
| D | 2023-05-24 | 2023-05-22 | VIR | NELSEN ROBERT | Dir, 10% | A - Grant | $0.00 | +6,027 | 576.1K | +1% | $0 |
| D | 2023-05-24 | 2023-05-22 | VIR | Ramasastry Saira | Dir | A - Grant | $0.00 | +6,027 | 14.1K | +74% | $0 |
| D | 2023-05-24 | 2023-05-22 | VIR | Hatfield Jeffrey S. | Dir | A - Grant | $0.00 | +6,027 | 15.8K | +62% | $0 |
| D | 2023-05-24 | 2023-05-22 | VIR | Sigal Charles Elliott | Dir | A - Grant | $0.00 | +6,027 | 15.8K | +62% | $0 |
| D | 2023-05-24 | 2023-05-22 | VIR | PEREZ ROBERT J | Dir | A - Grant | $0.00 | +6,027 | 15.8K | +62% | $0 |
| D | 2023-05-24 | 2023-05-22 | VIR | Napolitano Janet | Dir | A - Grant | $0.00 | +6,027 | 15.8K | +62% | $0 |
| D | 2023-05-24 | 2023-05-22 | VIR | SHARP PHILLIP A | Dir | A - Grant | $0.00 | +6,027 | 121.2K | +5% | $0 |
| D | 2023-05-24 | 2023-05-22 | VIR | MORE ROBERT J | Dir | A - Grant | $0.00 | +6,027 | 45.1K | +15% | $0 |
| D | 2023-05-24 | 2023-05-22 | VIR | SATO VICKI L | Dir | A - Grant | $0.00 | +6,027 | 1.33M | +0.5% | $0 |
| MI | 2023-05-23 | 2023-05-19+ | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $25.55 | -183.5K | 17.45M | -1% | -$4.69M |
| I | 2023-05-09 | 2023-05-05 | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $25.10 | -136 | 17.64M | -0.0% | -$3,414 |
| MI | 2023-05-05 | 2023-05-03+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $25.53 | -198.0K | 17.64M | -1% | -$5.06M |
| I | 2023-05-03 | 2023-05-01 | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $25.30 | -3,075 | 17.83M | -0.0% | -$77.8K |
| MI | 2023-04-26 | 2023-04-24+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $25.42 | -67.0K | 17.84M | -0.4% | -$1.70M |
| MI | 2023-04-24 | 2023-04-20+ | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $25.76 | -312.0K | 18.21M | -2% | -$8.04M |
| MI | 2023-04-20 | 2023-04-18+ | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $25.12 | -83.1K | 18.29M | -0.5% | -$2.09M |
| MI | 2023-04-18 | 2023-04-14+ | VIR | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | S - Sale | $25.08 | -20.1K | 18.30M | -0.1% | -$503.9K |
| D | 2023-04-04 | 2023-04-03 | VIR | De Backer Marianne | CEO | A - Grant | $0.00 | +576.5K | 576.5K | New | $0 |
| 2023-03-31 | 2023-03-30 | VIR | HANLY ANN M. | CTO | S - Sale | $22.77 | -2,627 | 114.6K | -2% | -$59.8K | |
| D | 2023-03-29 | 2023-03-27 | VIR | Lee Sung | CFO | A - Grant | $0.00 | +66.5K | 66.5K | New | $0 |
| 2023-03-09 | 2023-03-08 | VIR | SATO VICKI L | Dir | S - Sale | $22.59 | -17.9K | 1.33M | -1% | -$405.2K | |
| 2023-03-07 | 2023-03-03 | VIR | Friedl-Naderer Johanna | EVP, COO | S - Sale | $22.82 | -1,482 | 148.5K | -1.0% | -$33.8K | |
| I | 2023-03-02 | 2023-03-01 | VIR | Sigal Charles Elliott | Dir | P - Purchase | $22.73 | +2,500 | 10.0K | +33% | +$56.8K |
| M | 2023-02-28 | 2023-02-27 | VIR | Pang Phillip | Chief Medical Off | S - Sale | $23.08 | -10.3K | 188.0K | -5% | -$238.1K |
| D | 2023-02-24 | 2023-02-23 | VIR | Rice Steven J. | Chief Administrative Off | S - Sale | $25.97 | -1,795 | 108.4K | -2% | -$46.6K |
| D | 2023-02-24 | 2023-02-22 | VIR | Rice Steven J. | Chief Administrative Off | A - Grant | $0.00 | +73.0K | 110.2K | +196% | $0 |
| D | 2023-02-24 | 2023-02-22 | VIR | Friedl-Naderer Johanna | EVP, COO | A - Grant | $0.00 | +60.0K | 150.0K | +67% | $0 |
| D | 2023-02-24 | 2023-02-23 | VIR | HANLY ANN M. | CTO | S - Sale | $25.97 | -2,302 | 117.2K | -2% | -$59.8K |
| D | 2023-02-24 | 2023-02-22 | VIR | HANLY ANN M. | CTO | A - Grant | $0.00 | +37.5K | 119.5K | +46% | $0 |
| D | 2023-02-24 | 2023-02-22 | VIR | Pang Phillip | Chief Medical Off | A - Grant | $0.00 | +60.0K | 201.2K | +42% | $0 |
| D | 2023-02-24 | 2023-02-23 | VIR | Pang Phillip | Chief Medical Off | S - Sale | $25.97 | -2,878 | 198.3K | -1% | -$74.7K |
| M | 2023-02-24 | 2023-02-23+ | VIR | SCANGOS GEORGE A | Pres, CEO, Dir | S - Sale | $24.53 | -27.8K | 168.5K | -14% | -$680.8K |
| 2023-02-24 | 2023-02-23 | VIR | Horn Howard | CFO | S - Sale | $25.97 | -2,248 | 230.7K | -1.0% | -$58.4K | |
| MI | 2023-02-23 | 2023-02-21 | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $28.43 | -74.5K | 18.39M | -0.4% | -$2.12M |
| MI | 2023-02-21 | 2022-12-21+ | VIR | SCANGOS GEORGE A | Pres, CEO, Dir | J - Other | $0.00 | 0 | 179.9K | New | $0 |
| M | 2023-02-21 | 2023-02-17+ | VIR | SCANGOS GEORGE A | Pres, CEO, Dir | S - Sale | $27.23 | -27.8K | 196.2K | -12% | -$755.6K |
| 2023-02-21 | 2023-02-17 | VIR | Rice Steven J. | Chief Administrative Off | S - Sale | $25.29 | -1,981 | 37.2K | -5% | -$50.1K | |
| 2023-02-21 | 2023-02-17 | VIR | Horn Howard | CFO | S - Sale | $25.29 | -2,424 | 233.0K | -1% | -$61.3K | |
| 2023-02-21 | 2023-02-17 | VIR | Pang Phillip | Chief Medical Off | S - Sale | $25.29 | -2,802 | 141.2K | -2% | -$70.9K | |
| I | 2023-02-17 | 2023-02-15 | VIR | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | S - Sale | $26.75 | -39.0K | 18.39M | -0.2% | -$1.04M |
| MI | 2023-02-15 | 2023-02-13+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $26.28 | -118.0K | 18.43M | -0.6% | -$3.10M |
| MI | 2023-02-13 | 2023-02-09+ | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $26.28 | -234.3K | 18.55M | -1% | -$6.16M |
| M | 2023-02-09 | 2023-02-08 | VIR | SATO VICKI L | Dir | S - Sale | $28.37 | -17.9K | 1.35M | -1% | -$508.3K |
| MI | 2023-02-09 | 2023-02-07+ | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $28.52 | -145.4K | 18.79M | -0.8% | -$4.15M |
| MI | 2023-02-07 | 2023-02-03+ | VIR | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | S - Sale | $30.21 | -114.0K | 18.98M | -0.6% | -$3.45M |
| MI | 2023-02-03 | 2023-02-01+ | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $29.41 | -148.6K | 19.13M | -0.8% | -$4.37M |
| MI | 2023-02-01 | 2023-01-30+ | VIR | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | S - Sale | $29.46 | -152.8K | 19.26M | -0.8% | -$4.50M |
| MI | 2023-01-25 | 2023-01-23 | VIR | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | S - Sale | $28.34 | -36.5K | 19.38M | -0.2% | -$1.03M |
| DM | 2023-01-25 | 2023-01-24 | VIR | Pang Phillip | Chief Medical Off | A - Grant | $2.13 | +30.0K | 174.0K | +21% | +$63.9K |
| D | 2023-01-25 | 2023-01-24 | VIR | Pang Phillip | Chief Medical Off | S - Sale | $30.00 | -30.0K | 144.0K | -17% | -$900.0K |
| MI | 2023-01-23 | 2023-01-19+ | VIR | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | S - Sale | $27.13 | -214.2K | 19.53M | -1% | -$5.81M |
| MI | 2023-01-19 | 2023-01-17+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $26.28 | -190.8K | 19.60M | -1.0% | -$5.01M |
| MI | 2023-01-17 | 2023-01-12+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $26.58 | -211.7K | 19.79M | -1% | -$5.63M |
| MI | 2023-01-12 | 2023-01-10+ | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $26.32 | -149.6K | 20.08M | -0.7% | -$3.94M |
| 2023-01-11 | 2023-01-09 | VIR | SATO VICKI L | Dir | S - Sale | $25.83 | -17.9K | 1.36M | -1% | -$462.7K | |
| MI | 2023-01-10 | 2023-01-06+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $26.03 | -101.0K | 20.18M | -0.5% | -$2.63M |
| I | 2023-01-09 | 2023-01-05 | VIR | Sigal Charles Elliott | Dir | P - Purchase | $24.96 | +2,500 | 7,500 | +50% | +$62.4K |
| MI | 2023-01-05 | 2023-01-03+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $25.57 | -9,177 | 20.25M | -0.0% | -$234.6K |
| MI | 2023-01-05 | 2023-01-03+ | VIR | Sigal Charles Elliott | Dir | P - Purchase | $25.43 | +5,000 | 5,000 | New | +$127.1K |
| I | 2023-01-03 | 2022-12-29 | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $25.55 | -44.2K | 20.26M | -0.2% | -$1.13M |
Purchase Sale Sale after option exercise All abbreviations